TickerFacts.

Actuate Therapeutics, Inc. (ACTU): Shareholders' Equity

Annual figures by period end, from SEC filings.

$7.92M
As of 2025-12-31
$989.2K
As of 2026-06-30
2023-12-31: -$99.63M2024-12-31: $104.2K2025-12-31: $7.92M$7.92M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$7.92Mn/m2026-03-26, Balance as of period end
2024-12-31$104.2Kn/m2026-03-26, Balance as of period end
2023-12-31-$99.63Mn/a2025-03-13, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Actuate Therapeutics, Inc. (ACTU)2025-12-31$7.92Mn/m
Exicure, Inc. (XCUR)2025-12-31$3.93M-42.0%
CytoDyn Inc. (CYDY)2026-05-31-$109.72Mn/m
Biovie Inc. (BIVI)2026-06-30$10.27M-46.0%
Chemomab Therapeutics Ltd. (CMMB)2025-12-31$12.33M-8.9%
CalciMedica, Inc. (CALC)2025-12-31-$6.64Mn/m
Edesa Biotech, Inc. (EDSA)2025-09-30$12.45M+528.5%
Cellectar Biosciences, Inc. (CLRB)2025-12-31$8.54M-40.3%
Cingulate Inc. (CING)2025-12-31$2.51M-66.3%

Compare ACTU, XCUR, CYDY, BIVI side by side · Screen every company in Pharmaceutical Preparations ↗